Safety of targeting tumor endothelial cell antigens-Reference-Cited by-同舟云学术

Safety of targeting tumor endothelial cell antigens

Published:2016-04-12 Issue:1 Volume:14 Page:
ISSN:1479-5876
Container-title:Journal of Translational Medicine
language:en
Short-container-title:J Transl Med

Author:

Wagner Samuel C.,Riordan Neil H.,Ichim Thomas E.,Szymanski Julia,Ma Hong,Perez Jesus A.,Lopez Javier,Plata-Munoz Juan J.,Silva Francisco,Patel Amit N.,Kesari Santosh

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://link.springer.com/content/pdf/10.1186/s12967-016-0842-8

Reference93 articles.

1. HoptionCann SA, van Netten JP, van Netten C. Dr William Coley and tumour regression: a place in history or in the future. Postgrad Med J. 2003;79(938):672–80.

2. Monjazeb AM, et al. The role of antigen-specific and non-specific immunotherapy in the treatment of cancer. J Immunotoxicol. 2012;9(3):248–58.

3. Chiang CL, Coukos G, Kandalaft LE. Whole tumor antigen vaccines: where are we? Vaccines (Basel). 2015;3(2):344–72.

4. Miska J, Devarajan P, Chen Z. The immunological identity of tumor: self implications. Oncoimmunology. 2013;2(4):e23794.

5. Gilboa E. The makings of a tumor rejection antigen. Immunity. 1999;11(3):263–70.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vaccines targeting angiogenesis in melanoma;European Journal of Pharmacology;2021-12

2. Beyond cancer cells: Targeting the tumor microenvironment with gene therapy and armed oncolytic virus;Molecular Therapy;2021-05

3. Dendritic cell vaccine therapy for colorectal cancer;Pharmacological Research;2021-02

4. Therapeutic cancer vaccine: building the future from lessons of the past;Seminars in Immunopathology;2018-07-05

5. T-lymphocyte homing: an underappreciated yet critical hurdle for successful cancer immunotherapy;Laboratory Investigation;2017-03-27